Clinical Trial Results: Positive data boosts investor confidence, driving up the stock. Conversely, negative results can lead to significant price declines.

Regulatory Approvals: Approval of Argenx's drugs by regulatory bodies like the FDA signals commercial viability and increases stock value.

Competition: The emergence of competing therapies or drugs can negatively impact Argenx's market share and stock price.

Market Sentiment: Overall market conditions and investor sentiment towards the biotechnology sector influence ARGX.US.

Financial Performance: Strong revenue growth and profitability reports typically lead to higher stock prices.

Partnerships and Collaborations: Strategic alliances with other pharmaceutical companies can create investor excitement and positively affect the stock.

Patent Protection: Strong patent coverage protects Argenx's intellectual property and supports long-term value.

Management Changes: Key leadership changes can sometimes impact investor confidence, affecting the stock price.